Orkla ASA (LON:0FIN)

Market Cap	7.96B
Revenue (ttm)	5.18B
Net Income (ttm)	761.91M
Shares Out	n/a
EPS (ttm)	0.76
PE Ratio	10.45
Forward PE	16.46
Dividend	0.72 (0.66%)
Ex-Dividend Date	Apr 25, 2025

Volume	22,555
Average Volume	91,094
Open	110.30
Previous Close	109.50
Day's Range	110.00 - 110.80
52-Week Range	89.45 - 125.10
Beta	0.07
RSI	56.96
Earnings Date	Jul 14, 2025

About Blueprint Medicines

Orkla ASA operates as an industrial investment company within brands and consumer-oriented businesses in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery channels, as well as food service, convenience stores, and petrol stations. It also provides confectionery, biscuit, and snack products; and spices, masalas, and food products based on dried mixes. In addition, t...

• Industry: Conglomerates
• Founded: 1918
• Employees: 19,080
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0FIN

Financial Performance

In 2024, Orkla ASA's revenue was 70.66 billion, an increase of 4.22% compared to the previous year's 67.80 billion. Earnings were 6.06 billion, an increase of 16.57%.